On the other hand, the ability of ALT, expressed as a continuous variable, to predict NAFLD among T2DM was good (AUC = 0.701, 95% CI: 0.637–0.761). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.